#1 Clinical Trials Search in Europe

Clonidine Hydrochloride

Clonidine Hydrochloride, a versatile medication, is being studied in several clinical trials for its potential benefits in treating various medical conditions. These trials aim to evaluate the drug’s efficacy and safety in addressing issues such as attention deficit hyperactivity disorder (ADHD), neonatal abstinence syndrome, painful diabetic neuropathy, and more. This article provides an overview of the ongoing research and potential applications of Clonidine Hydrochloride in clinical settings.

Table of Contents

What is Clonidine Hydrochloride?

Clonidine Hydrochloride, also known by brand names such as Kapvay, Catapres, Duraclon, and Nexiclon, is a medication that belongs to a class of drugs called alpha-2 adrenergic agonists[1]. This means it works by stimulating certain receptors in the brain and body that help regulate various functions, including blood pressure, pain sensation, and certain behaviors[2].

Medical Uses of Clonidine

Clonidine Hydrochloride is used to treat several medical conditions:

  • Attention Deficit Hyperactivity Disorder (ADHD): Clonidine can help manage symptoms of ADHD in children and adolescents[3].
  • Hypertension: It’s used to treat high blood pressure, particularly in postpartum women with hypertensive disorders of pregnancy[4].
  • Pain Management: Clonidine can be used to manage certain types of pain, including painful diabetic neuropathy (nerve pain caused by diabetes)[1].
  • Opioid Withdrawal: It’s used to help treat withdrawal symptoms in infants born to mothers who used opioids during pregnancy, a condition known as Neonatal Abstinence Syndrome[5].
  • Anesthesia: Clonidine can be used as part of anesthesia procedures to help with pain control and sedation[2].

How Clonidine is Administered

Clonidine can be given in several ways, depending on the condition being treated:

  • Oral tablets: For conditions like ADHD, clonidine is often given as a pill to be taken by mouth[3].
  • Topical gel: For pain management, such as in diabetic neuropathy, clonidine may be applied as a gel directly to the skin[1].
  • Injections: In some medical procedures, clonidine can be injected into the space around the spinal cord (epidural space) or into specific areas of the body for pain control[2].
  • Transdermal patch: Some forms of clonidine can be administered through a patch placed on the skin[6].

Effectiveness of Clonidine

Research has shown that clonidine can be effective for its various uses:

  • In children with ADHD, clonidine has been shown to help maintain improvement in symptoms over long periods[3].
  • For pain management, studies have found that clonidine can help reduce pain intensity in conditions like diabetic neuropathy[1].
  • In treating neonatal abstinence syndrome, clonidine has shown promise in reducing the severity of withdrawal symptoms and the time needed for treatment[7].

Potential Side Effects

Like all medications, clonidine can cause side effects. Some potential side effects include:

  • Drowsiness or sedation: Clonidine can make you feel sleepy or tired[3].
  • Changes in blood pressure: It may cause your blood pressure to drop, especially when you first start taking it[6].
  • Dry mouth
  • Dizziness
  • Constipation

It’s important to discuss any side effects with your healthcare provider. They can help determine if the benefits of the medication outweigh the risks for your specific situation.

Ongoing Research and Future Prospects

Researchers continue to study clonidine to better understand its effects and potential new uses:

  • Studies are looking at the use of clonidine in combination with other medications for pain management during and after surgery[2].
  • Research is ongoing to determine the best ways to use clonidine for treating opioid withdrawal in infants[7].
  • Scientists are investigating the potential of clonidine to reduce heart-related complications after non-cardiac surgery[6].

As with any medication, it’s crucial to take clonidine only as prescribed by your healthcare provider. They can provide personalized advice based on your specific medical condition and overall health status.

Condition Study Type Key Findings/Objectives
ADHD Double-blind, placebo-controlled Evaluating long-term efficacy and safety of KAPVAY™ (Clonidine Hydrochloride) extended-release in children and adolescents
Neonatal Abstinence Syndrome Prospective, double-blind, randomized controlled Comparing efficacy of Clonidine vs. morphine in treating opioid withdrawal in infants
Painful Diabetic Neuropathy Randomized, double-blind, parallel-group Assessing efficacy and safety of Clonidine Hydrochloride topical gel for pain management
Delirium in Cardiac Surgery Patients Randomized, double-blinded, controlled Comparing Dexmedetomidine vs. Clonidine for controlling delirium in CABG patients
Perioperative Ischemia Randomized, double-blinded Evaluating Clonidine for reducing cardiac morbidity and mortality following non-cardiac surgery

FAQ

  • What is Clonidine Hydrochloride? Clonidine Hydrochloride is a medication that belongs to a class of drugs called central alpha-2 agonists. It works by affecting certain chemicals in the brain and nervous system, and is being studied for various medical conditions.
  • What conditions are being studied with Clonidine Hydrochloride? Clinical trials are exploring the use of Clonidine Hydrochloride for conditions such as Attention Deficit Hyperactivity Disorder (ADHD), Neonatal Abstinence Syndrome (NAS), painful diabetic neuropathy, and delirium in patients undergoing cardiac surgery.
  • How is Clonidine Hydrochloride administered in these trials? The administration of Clonidine Hydrochloride varies depending on the study. It may be given orally, intravenously, or applied topically as a gel. The dosage and frequency also differ based on the condition being treated and the specific trial protocol.
  • Are there any side effects associated with Clonidine Hydrochloride? Like all medications, Clonidine Hydrochloride may have side effects. Common ones observed in trials include changes in blood pressure, heart rate, and drowsiness. However, the full safety profile is still being evaluated in these clinical studies.
  • How long do these clinical trials typically last? The duration of clinical trials for Clonidine Hydrochloride varies widely. Some studies last for a few weeks, while others may continue for several months or even up to a year, depending on the condition being studied and the specific research objectives.

Ongoing Clinical Trials on Clonidine Hydrochloride

  • Study Comparing Serratus Plane Block, Capsaicin, and Botulinum Toxin Type A for Chronic Pain in Post-Mastectomy Patients

    Recruiting

    1 1 1
    Investigated drugs:
    France

  • Study Comparing Intrathecal Morphine and TAP Block with Ropivacaine and Clonidine for Pain Relief in Patients Undergoing Elective Cesarean Section

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Clonidine Hydrochloride for Pain Relief During Eye Exams in Premature Infants with Retinopathy of Prematurity

    Recruiting

    1 1 1 1
    Investigated drugs:
    Sweden

  • Study on Dexmedetomidine and Clonidine Hydrochloride to Prevent Delirium in Patients Undergoing Open Heart Surgery

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Norway

  • Study on Opioid Detoxification Using Buprenorphine, Naloxone, and Oxycodone for Patients with Persistent Spinal Pain Syndrome Type II

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium

  • Study on Preventing Agitation After Anesthesia in Children Aged 1 Year or Younger Using Clonidine Hydrochloride and Sodium Chloride

    Not yet recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study of clonidine for pain relief in patients after colon surgery

    Not yet recruiting

    1 1 1
    Investigated drugs:
    Denmark

  • Clonidine Hydrochloride for Pain Management After Spine Surgery in Patients with Degenerative Spine Diseases

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Evaluation of clonidine and doxazosin for treating nightmares in adults with Post-traumatic Stress Disorder

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Germany

Glossary

  • ADHD: Attention Deficit Hyperactivity Disorder, a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity.
  • Neonatal Abstinence Syndrome (NAS): A group of conditions caused when a baby withdraws from certain drugs they were exposed to in the womb before birth.
  • Diabetic Neuropathy: A type of nerve damage that can occur in people with diabetes, often causing pain and numbness in the feet and legs.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.
  • Pharmacodynamics: The study of the biochemical and physiological effects of drugs on the body, including their mechanisms of action.
  • Placebo: A substance or treatment with no active therapeutic effect, used as a control in clinical trials.
  • Double-blind study: A research design where neither the participants nor the researchers know who is receiving the experimental treatment and who is receiving the placebo or standard treatment.
  • Efficacy: The ability of a drug or treatment to produce the desired beneficial effect.
  • Adverse Events: Any unfavorable and unintended sign, symptom, or disease temporarily associated with the use of a medical treatment or procedure.
  • Randomized Controlled Trial: A type of scientific experiment where participants are randomly allocated to receive either the experimental treatment or a control treatment.

References

  1. https://clinicaltrials.gov/study/NCT02643251
  2. https://clinicaltrials.gov/study/NCT03155646
  3. https://clinicaltrials.gov/study/NCT01439126
  4. https://clinicaltrials.gov/study/NCT01761916
  5. https://clinicaltrials.gov/study/NCT00510016
  6. https://clinicaltrials.gov/study/NCT00335582
  7. https://clinicaltrials.gov/study/NCT01360450